Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

90.21
+0.26000.29%
Post-market: 90.210.00000.00%19:50 EDT
Volume:2.04M
Turnover:184.25M
Market Cap:52.01B
PE:52.48
High:90.41
Open:89.98
Low:89.55
Close:89.95
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.74
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.90
PE(LYR):49.22

Loading ...

Edwards Lifesciences options imply 6.5% move in share price post-earnings

TIPRANKS
·
Jul 24

Press Release: Visionwave and Meteor Aerospace Leadership Advance Integration Planning for Ai-enabled Multi-domain Defense Technologies Following Previously Announced Acquisition Agreement

Dow Jones
·
Jul 23

Edwards Lifesciences: Buy Rating Reaffirmed as Analyst Lifts Price Target from $85 to $104 on TAVR Momentum and TMTT Catalysts

TIPRANKS
·
Jul 22

Edwards Lifesciences (EW) Faces FTC Penalty, Is The Stock Still Cheap?

Simply Wall St.
·
Jul 18

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Edwards Lifesciences Expands Pediatric Heart Portfolio With Autus Valve Access Study

TIPRANKS
·
Jul 18

QTREX Quantum Appoints Ex-nano Dimension R&D Chief Chappel-ram as Independent Director

Reuters
·
Jul 17

How Investors Are Reacting To Edwards Lifesciences (EW) Record FTC HSR Penalty And Added Oversight

Simply Wall St.
·
Jul 17

Edwards Lifesciences is Maintained at Hold by Truist Securities

Dow Jones
·
Jul 17

Abbott Raises 2026 Profit Forecast on Heart Device Strength

Reuters
·
Jul 16

Edwards Lifesciences to Host Quarterly Earnings Conference Call

Reuters
·
Jul 16

Earning Preview: Edwards Lifesciences this quarter’s revenue is expected to increase by 14.19%, and institutional views are bullish

Earnings Agent
·
Jul 16

Jenscare Completes First Implants in FDA Pivotal Trial for Lux-valve Plus Tricuspid Valve System

Reuters
·
Jul 16

Mizuho Adjusts Price Target on Edwards Lifesciences to $105 From $100, Maintains Outperform Rating

MT Newswires Live
·
Jul 15

Movement Alert|Edwards Lifesciences Falls 3.21% in Regular Trading, Trading at $87.355

Market Focus
·
Jul 15

Analysts See Risks for Elective-procedure Medtechs After HCA Cuts Profit Forecast

Reuters
·
Jul 15

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Movement Alert|Edwards Lifesciences Falls 3.28% in Regular Trading, Trading at $89.91

Market Focus
·
Jul 14

Edwards Lifesciences, Genesis Medtech to Pay Combined $12M to Settle FTC Charges

Dow Jones
·
Jul 14

Edwards Lifesciences is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 13